We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
+14.03%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$2.38B
AUM Growth
+$187M
(+8.5%)
Cap. Flow
-$70.5M
Cap. Flow
% of AUM
-2.96%
Top 10 Holdings %
Top 10 Hldgs %
22.58%
Holding
715
New
163
Increased
137
Reduced
189
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$25.4M |
| 2 |
BHI
Baker Hughes
BHI
|
+$23.6M |
| 3 |
Verizon
VZ
|
+$20.1M |
| 4 |
Microsoft
MSFT
|
+$16.9M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$27.3M |
| 2 |
IBM
IBM
|
+$26.1M |
| 3 |
International Paper
IP
|
+$21.4M |
| 4 |
Cisco
CSCO
|
+$19.4M |
| 5 |
GAP
The Gap Inc
GAP
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.23% |
| 2 | Consumer Discretionary | 16.11% |
| 3 | Healthcare | 14.46% |
| 4 | Financials | 12.23% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBHC
276
DELISTED
The Brand House Collective
TBHC
| $500K | 0.02% |
21,180
+399
| +2% | +$8.36K |
|
277
AngioDynamics
ANGO
$624M
| $492K | 0.02% |
+28,622
| New | +$440K |
|
278
Pampa Energía
PAM
$4.56B
| $488K | 0.02% |
+93,024
| New | +$532K |
|
279
Helen of Troy
HELE
$677M
| $480K | 0.02% |
+9,679
| New | +$454K |
|
280
UFP Industries
UFPI
$5.16B
| $478K | 0.02% |
+27,507
| New | +$453K |
|
|
DMC
281
Del Monte Corp
DMC
$1.41B
| $469K | 0.02% |
16,574
-423
| -2% | -$11.9K |
|
282
Hexcel
HXL
$7.9B
| $463K | 0.02% |
+10,334
| New | +$437K |
|
283
Washington Trust Bancorp
WASH
$747M
| $462K | 0.02% |
12,400
| – | – |
|
284
Columbus McKinnon
CMCO
$614M
| $458K | 0.02% |
16,899
-600
| -3% | -$15.7K |
|
|
MGI
285
DELISTED
MoneyGram International, Inc. New
MGI
| $453K | 0.02% |
+21,803
| New | +$443K |
|
286
Charles River Laboratories
CRL
$12.4B
| $445K | 0.02% |
8,397
+8,354
| +19,428% | +$420K |
|
|
ECHO
287
EchoStar
ECHO
$25.6B
| $443K | 0.02% |
+10,999
| New | +$430K |
|
288
First Busey Corp
BUSE
$2.6B
| $430K | 0.02% |
+24,680
| New | +$409K |
|
289
Ducommun
DCO
$3.08B
| $427K | 0.02% |
14,328
-6,514
| -31% | -$177K |
|
|
LTS
290
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $426K | 0.02% |
+136,116
| New | +$343K |
|
|
AVX
291
DELISTED
AVX Corporation
AVX
| $424K | 0.02% |
+30,462
| New | +$413K |
|
|
AVTA
292
DELISTED
Avantax, Inc. Common Stock
AVTA
| $423K | 0.02% |
14,496
-19,636
| -58% | -$530K |
|
|
HLSS
293
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
| $423K | 0.02% |
18,405
-106,993
| -85% | -$2.47M |
|
294
Employers Holdings
EIG
$910M
| $418K | 0.02% |
13,216
-1,619
| -11% | -$50.1K |
|
295
WesBanco
WSBC
$4B
| $415K | 0.02% |
12,941
+320
| +3% | +$9.71K |
|
296
Hurco Companies Inc
HURC
$142M
| $410K | 0.02% |
16,356
-2,787
| -15% | -$70.1K |
|
297
Arbor Realty Trust
ABR
$966M
| $409K | 0.02% |
61,461
-1,718
| -3% | -$11.5K |
|
|
CCRN
298
DELISTED
Cross Country Healthcare
CCRN
| $397K | 0.02% |
+39,817
| New | +$276K |
|
299
Foster
FSTR
$438M
| $367K | 0.02% |
7,740
-85
| -1% | -$3.89K |
|
300
Myers Industries
MYE
$1.32B
| $366K | 0.02% |
17,327
-5,500
| -24% | -$107K |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, ClariVest Asset Management held 715 positions worth $2.38B, up 8.5% from $2.19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ClariVest Asset Management's Q4 2013 filing shows 163 new, 137 increased, 189 reduced and 128 closed positions. Its largest new stake was Johnson & Johnson: 275,639 shares worth $25.2M. The largest sale was Allergan plc, an estimated $27.3M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- ClariVest Asset Management's largest Q4 2013 buy was Johnson & Johnson: 275,639 shares worth $25.2M.
- ClariVest Asset Management added most to Verizon in Q4 2013, an estimated $20.1M increase.
- ClariVest Asset Management's biggest Q4 2013 reduction was IBM, cutting an estimated $26.1M.
- ClariVest Asset Management fully exited Allergan plc in Q4 2013, selling an estimated $27.3M.
- ClariVest Asset Management's ten largest holdings make up 23% of its $2.38B portfolio in Q4 2013.
- ClariVest Asset Management opened 163 new positions and closed 128 in Q4 2013.
- ClariVest Asset Management's portfolio value rose 8.5% quarter-over-quarter to $2.38B.
Based on ClariVest Asset Management's 13F filing for Q4 2013, filed 10 Feb 2014.